Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

March 31, 2004

Conditions
Graft-versus-Host Disease
Interventions
DRUG

Methoxsalen

PROCEDURE

Extracorporeal Photopheresis

Trial Locations (31)

2010

St. Vincent's Hospital, Darlinghurst

3050

Royal Melbourne Hospital, Parkville

6100

Ankara University Medical School, Altındağ

16132

San Martino Hospital, Genova

19024

Fred Hutchinson Cancer Research Center, Seattle

32610

University of Florida, Gainesville

45122

Universitatis Hautklinik, Essen

45236

Jewish Hospital, Cincinnati

60612

Rush Presbyterian - St. Lukes Medical Center, Chicago

60637

University of Chicago, Chicago

64111

Kansas City Cancer Center, Kansas City

69437

Hopital Edouard Herriot, Lyon

72205

University of Arkansas for Medical Sciences, Little Rock

81103

Klinika hematologie a transfuziologie FN, Bratislava

02111

Tufts New England Medical Center, Boston

02115

Brigham and Womens, Boston

48109-0914

University of Michigan, Ann Arbor

68198-7680

University of Nebraska, Omaha

Unknown

Peter MacCallum, East Melbourne

Alfred Hospital, Melbourne

A-1090

General Hospital of Vienna, Vienna

F-75013

Hopital Pitie-Salpetriere, Paris

D-01307

University of Dresden, Dresden

D-04103

Universitatsklinikum Leipzig AOR, Leipzig

D-81377

Ludwig-Maximilians-Universitaet Muenchen, München

1-50134

Careggi Hospital, Florence

1099-023

Instituto Portugues de Oncologia de Francisco Gentil, Lisbon

E-08025

Hospital dela Santa Creu i Sant Pau. Universitat Autonoma de Barcelona, Barcelona

CH-4031

Kantonsspital Basel, Basel

S60 2UD

Rotherham General Hospital, Rotherham

G4 OS4

Glasgow Royal Infirmary, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY